Members Only Content
Subscribe to get full access
Free Preview
The biotechnology company had a novel approach using its PNA platform. But it's run out of cash, and we think its restructuring efforts will be too little, too late.
CPNG Recommendation Jan 2025
If you love dividends, now's a good time to go hunting. Several companies -- some well known, others not -- [...]
Did you just get a new credit card or did your existing one expire? If so, this article is for [...]
